Most people have heard at least something about glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, or GLP-1s
The peptide has gained significant scientific attention in longevity and regenerative medicine research due to its unique ability to induce apoptosis specifically in senescent cells while leaving healthy cells largely unaffected
GLP-1 medicines for weight loss You may be taking a GLP-1 medicine
As such, payers should consider: Starting members on tailored weight loss solutions before authorizing GLP-1 treatment coverage Covering holistic programs inclusive of GLP-1 therapies Including conditional terms that provide short-term coverage for GLP-1 patients and Transition patients on to longer-term sustainable programs, such as: Newtopias GLP-1 Sustain is a habit-changing platform that ensures short-term GLP-1 benefits last through long-term change, supporting an eventual positive ROI
Some of these drugs can be used to enhance training and become part of something bigger, but the concern is that people believe they are doing something beneficial for their wellbeing when that may not necessarily be the case
Keep the container airtight
